Biolase Gross Profit 2010-2023 | BIOL
Biolase gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Biolase Annual Gross Profit
(Millions of US $) |
| 2023 |
$17 |
| 2022 |
$16 |
| 2021 |
$17 |
| 2020 |
$6 |
| 2019 |
$14 |
| 2018 |
$17 |
| 2017 |
$15 |
| 2016 |
$20 |
| 2015 |
$16 |
| 2014 |
$18 |
| 2013 |
$22 |
| 2012 |
$26 |
| 2011 |
$21 |
| 2010 |
$9 |
| 2009 |
$20 |
Biolase Quarterly Gross Profit
(Millions of US $) |
| 2023-12-31 |
$4 |
| 2023-09-30 |
$4 |
| 2023-06-30 |
$6 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$5 |
| 2022-03-31 |
$5 |
| 2021-12-31 |
$5 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$4 |
| 2021-03-31 |
$3 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$2 |
| 2020-06-30 |
$1 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
$3 |
| 2019-03-31 |
$4 |
| 2018-12-31 |
$6 |
| 2018-09-30 |
$4 |
| 2018-06-30 |
$4 |
| 2018-03-31 |
$3 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$5 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$6 |
| 2016-06-30 |
$6 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$4 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$5 |
| 2014-09-30 |
$5 |
| 2014-06-30 |
$4 |
| 2014-03-31 |
$4 |
| 2013-12-31 |
$6 |
| 2013-09-30 |
$4 |
| 2013-06-30 |
$6 |
| 2013-03-31 |
$6 |
| 2012-12-31 |
$9 |
| 2012-09-30 |
$6 |
| 2012-06-30 |
$6 |
| 2012-03-31 |
$6 |
| 2011-12-31 |
$6 |
| 2011-09-30 |
$5 |
| 2011-06-30 |
$6 |
| 2011-03-31 |
$5 |
| 2010-12-31 |
$5 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$2 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$4 |
| 2009-09-30 |
$6 |
| 2009-06-30 |
$8 |
| 2009-03-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
